Jennifer Progesterone Injection

Adult administration

1. Amenorrhea: Administer 25mg of progesterone intramuscularly three times a week for the last two weeks of the menstrual cycle. 2. Dysmenorrhea and premenstrual syndrome: Inject 10-25mg of progesterone intramuscularly daily for one week before the start of menstruation. 3. Functional uterine bleeding: Inject 5-10mg of progesterone intramuscularly daily for five days until two days before the expected menstrual date. 4. Threatened miscarriage: Administer 10-50mg of progesterone intramuscularly one or two times a day.

This medication contains benzyl alcohol, which can be dangerous if used in premature or low birth weight infants. Therefore, it should not be administered to patients with certain diseases, pregnant women, nursing mothers, or newborns. In particular, patients with severe kidney disease, thrombotic disorders, severely impaired liver function, or breast cancer should also not use this medication. Use this medication with caution in patients with asthma, migraine, epilepsy, or heart or kidney disorders. Patients with a history of depression or diabetes may experience worsening conditions while using this medication, so careful administration is necessary. Various side effects such as bleeding, menstrual irregularities, skin rashes, liver function abnormalities, digestive symptoms, neurological symptoms, and vision problems may occur during administration, so it is important to consult medical personnel immediately if symptoms develop. When using this medication for an extended period, it is important to have regular breast and pelvic examinations to check for any side effects. If vision suddenly deteriorates or any abnormalities occur in the eyes, usage should be stopped immediately, and a medical examination should be sought. This medication should only be administered after confirming pregnancy, and when used for maintaining pregnancy, the pregnancy status should be checked regularly. This medication may interact with other drugs, so it is important to inform your healthcare provider of any medications being taken. Nursing women are advised to avoid using this medication, and there is no specific antidote for overdose, so appropriate treatment should be sought based on symptoms. This medication should only be administered by muscle injection, and other administration methods are not recommended.

Serious side effects

• Severe allergic reactions due to hypersensitivity (hives, severe swelling, etc.).
• Cholestatic jaundice due to liver abnormalities.
• Partial or complete loss of vision, double vision, or vision abnormalities due to retinal vascular lesions.
• Severe migraine and headaches.

Mild side effects

• Genitourinary system: Destructive bleeding, spotting, changes in menstrual volume, amenorrhea, cervical erosion, and changes in cervical discharge.
• Breast: Changes in breast tissue, breast swelling.
• Allergic reactions: Rashes may occur.
• Skin: Melasma, hyperpigmentation, allergic rashes with or without itching, acne, alopecia, hirsutism.
• Liver: Increased AST, ALT levels.
• Gastrointestinal: Nausea, vomiting, diarrhea.
• Central nervous system: Depression, insomnia.

This medication should be stored in a sealed container to prevent air entry, at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and ensure its safe use.

Appearance

A clear, viscous oily solution that is colorless to pale yellow in a transparent glass vial.

Package unit

10mL(vial) x Manufacturer packaging unit